KEARNY VENTURE PARTNERS
With over $330 million in capital under management, Kearny Venture Partners is a venture capital firm exclusively focused on healthcare products. We believe that the opportunity for entrepreneurs to devise innovative solutions in healthcare has never been greater. Significant unmet needs in healthcare continue to persist, representing large potential market opportunities for safe and effective products. As the molecular basis of disease is increasingly unraveled, new opportunities for intervention emerge. Novel therapies can and will displace incumbent products.
KEARNY VENTURE PARTNERS
Social Links:
Industry:
Financial Services Health Care Venture Capital
Status:
Active
Contact:
(415) 875-7770
Email Addresses:
[email protected]
Technology used in webpage:
SPF LetsEncrypt Apache Microsoft Exchange Online Office 365 Mail Unified Layer Google Adsense For Domains HostMonster No-ip
Similar Organizations
Echo Health Ventures
Echo Health Ventures is a venture capital firm that focuses on investing in health care companies.
Meritus Ventures
Meritus Ventures, L.P. (Meritus) is a $36.4 million venture capital fund formed to make equity investments in private, expansion-stage
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-07-01 | Cybin | Kearny Venture Partners investment in Series B - Cybin | 45 M CAD |
| 2017-03-16 | Aerpio Pharmaceuticals | Kearny Venture Partners investment in Venture Round - Aerpio Pharmaceuticals | 40 M USD |
| 2017-01-18 | ViewRay | Kearny Venture Partners investment in Post-IPO Equity - ViewRay | 26.1 M USD |
| 2016-08-22 | ViewRay | Kearny Venture Partners investment in Post-IPO Equity - ViewRay | 14 M USD |
| 2015-07-24 | ViewRay | Kearny Venture Partners investment in Post-IPO Equity - ViewRay | 26.7 M USD |
| 2014-04-23 | Aerpio Pharmaceuticals | Kearny Venture Partners investment in Series C - Aerpio Pharmaceuticals | 22 M USD |
| 2013-12-17 | ViewRay | Kearny Venture Partners investment in Venture Round - ViewRay | 30 M USD |
| 2013-11-18 | TriVascular | Kearny Venture Partners investment in Series E - TriVascular | 40 M USD |
| 2013-11-06 | Aerpio Pharmaceuticals | Kearny Venture Partners investment in Series A - Aerpio Pharmaceuticals | 36 M USD |
| 2013-10-04 | Boreal Genomics | Kearny Venture Partners investment in Series C - Boreal Genomics | 18 M USD |